BioTime, Inc. Announces David Schlachet's Decision Not Stand for Reelection as a Director at 2018 Annual Meeting of Shareholders
March 26, 2018 at 09:16 pm
On March 20, 2018, David Schlachet informed BioTime, Inc. during a regularly scheduled quarterly Board of Directors meeting that, for personal reasons he has decided to not stand for reelection as a director at 2018 annual meeting of shareholders. Mr. Schlachet’s decision was influenced by the logistics of serving as a director while residing in Israel. However, Mr. Schlachet remains committed to BioTime and will continue to serve as a director of Cell Cure Neurosciences Ltd., a subsidiary of BioTime, located in Jerusalem, Israel.